financetom
Business
financetom
/
Business
/
Helen of Troy's Fiscal Q3 Adjusted Earnings, Revenue Decline; Narrows Fiscal 2025 Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Helen of Troy's Fiscal Q3 Adjusted Earnings, Revenue Decline; Narrows Fiscal 2025 Guidance
Jan 8, 2025 4:46 AM

07:21 AM EST, 01/08/2025 (MT Newswires) -- Helen of Troy (HELE) reported fiscal Q3 adjusted earnings Wednesday of $2.67 per diluted share, down from $2.79 a year earlier.

Analysts polled by FactSet expected $2.38.

Revenue for the quarter ended Nov. 30 was $530.7 million, down from $549.6 million a year earlier.

Analysts surveyed by FactSet expected $532.9 million.

For fiscal 2025, the company said it now expects adjusted EPS of $7.15 to $7.40 from the previous range of $7 to $7.50. Analysts surveyed by FactSet expect $5.32.

The company also narrowed its fiscal 2025 revenue guidance to now be between about $1.89 billion and about $1.91 billion from the previous range of $1.89 billion to $1.94 billion. Analysts surveyed by FactSet expect $1.91 billion.

Shares of Helen of Troy were down more than 4% in recent premarket activity.

Price: 56.60, Change: -2.69, Percent Change: -4.54

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Gilead Sciences Gets Conditional Marketing Authorization for Liver Disease Treatment in European Economic Area
Gilead Sciences Gets Conditional Marketing Authorization for Liver Disease Treatment in European Economic Area
Feb 20, 2025
05:44 PM EST, 02/20/2025 (MT Newswires) -- Gilead Sciences ( GILD ) said the European Commission granted conditional marketing authorization for seladelpar in combination with ursodeoxycholic acid to treat primary biliary cholangitis, a rare liver disease. The treatment targets adults who have an inadequate response to UDCA alone, or as monotherapy in those unable to tolerate UDCA, the company said...
Former US energy secretary Granholm joins Edison International, Socal Edison boards
Former US energy secretary Granholm joins Edison International, Socal Edison boards
Feb 20, 2025
(Reuters) - Jennifer Granholm, the former U.S. secretary of energy and a Democratic two-term governor of Michigan, has been appointed to the boards of Edison International ( EIX ) and its subsidiary, Southern California Edison, effective April 1, the company announced on Thursday. Granholm brings extensive experience in energy policy, particularly in advancing clean energy initiatives and zero-carbon technologies, from...
BRIEF-Drugs Made In America Acquisition Corp. Announces The Separate Trading Of Its Ordinary Shares And Rights, Commencing February 25, 2025
BRIEF-Drugs Made In America Acquisition Corp. Announces The Separate Trading Of Its Ordinary Shares And Rights, Commencing February 25, 2025
Feb 20, 2025
Feb 20 (Reuters) - Drugs Made In America Acquisition Corp ( DMAAU ): * DRUGS MADE IN AMERICA ACQUISITION CORP. ( DMAAU ) ANNOUNCES THE SEPARATE TRADING OF ITS ORDINARY SHARES AND RIGHTS, COMMENCING FEBRUARY 25, 2025 Source text: Further company coverage: ...
BRIEF-Celsius Holdings To Acquire Alani Nu
BRIEF-Celsius Holdings To Acquire Alani Nu
Feb 20, 2025
Feb 20 (Reuters) - Celsius Holdings Inc ( CELH ): * CELSIUS HOLDINGS TO ACQUIRE ALANI NU®, CREATING A LEADING BETTER-FOR-YOU, FUNCTIONAL LIFESTYLE PLATFORM * CELSIUS HOLDINGS INC ( CELH ) - TO ACQUIRE ALANI NU FOR $1.65 BILLION * CELSIUS HOLDINGS INC ( CELH ) - DEAL EXPECTED TO BE ACCRETIVE TO CASH EPS IN FIRST YEAR * CELSIUS...
Copyright 2023-2026 - www.financetom.com All Rights Reserved